Minimally Invasive Pharmacokinetic and Pharmacodynamic Technologies in Hypothesis-Testing Clinical Trials of Innovative Therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Minimally Invasive Pharmacokinetic and Pharmacodynamic Technologies in Hypothesis-Testing Clinical Trials of Innovative Therapies

Published:2006-05-03 Issue:9 Volume:98 Page:580-598
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Workman Paul,Aboagye Eric O.,Chung Yuen-Li,Griffiths John R.,Hart Rachel,Leach Martin O.,Maxwell Ross J.,McSheehy Paul M. J.,Price Pat M.,Zweit Jamal

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/98/9/580/7688604/djj162.pdf

Reference178 articles.

1. Garrett MD, Workman P. Discovering novel chemotherapeutic drugs for the third millennium. Eur J Cancer1999 ; 35 : 2010 –30.

2. Gibbs JB. Mechanism-based target identification and drug discovery in cancer research. Science2000 ; 287 : 1969 –73.

3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell2000 ; 100 : 57 –70.

4. Kaelin WG. Choosing anticancer drug targets in the post-genomic era. J Clin Invest1999 ; 104 : 1503 –6.

5. Workman P. The opportunities and challenges of personalized genome-based molecular therapies for cancer: Targets, technologies and molecular chaperones. Cancer Chemother Pharmacol2003 ; 52 Suppl 1: S45 –56.

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measuring repeatability of dynamic contrast-enhanced MRI biomarkers improves evaluation of biological response to radiotherapy in lung cancer;European Radiology;2024-08-09

2. Criteria for assessing evidence for biomarker-targeted therapies in rare cancers—an extrapolation framework;Therapeutic Advances in Medical Oncology;2024-01

3. Future Directions and Challenges in Overcoming Drug Resistance in Cancer;Drug Resistance in Cancer: Mechanisms and Strategies;2024

4. MicroRNAs: The next generation of cancer biomarkers;Biomedical Letters;2023-08-13

5. The Blood-Brain Barrier: Implications for Experimental Cancer Therapeutics;Annual Review of Cancer Biology;2023-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3